---
input_text: Translation initiator EIF4G1 mutations in familial Parkinson disease.Genome-wide
  analysis of a multi-incident family with autosomal-dominant parkinsonism has implicated
  a locus on chromosomal region 3q26-q28. Linkage and disease segregation is explained
  by a missense mutation c.3614G>A (p.Arg1205His) in eukaryotic translation initiation
  factor 4-gamma (EIF4G1). Subsequent sequence and genotype analysis identified EIF4G1
  c.1505C>T (p.Ala502Val), c.2056G>T (p.Gly686Cys), c.3490A>C (p.Ser1164Arg), c.3589C>T
  (p.Arg1197Trp) and c.3614G>A (p.Arg1205His) substitutions in affected subjects with
  familial parkinsonism and idiopathic Lewy body disease but not in control subjects.
  Despite different countries of origin, persons with EIF4G1 c.1505C>T (p.Ala502Val)
  or c.3614G>A (p.Arg1205His) mutations appear to share haplotypes consistent with
  ancestral founders. eIF4G1 p.Ala502Val and p.Arg1205His disrupt eIF4E or eIF3e binding,
  although the wild-type protein does not, and render mutant cells more vulnerable
  to reactive oxidative species. EIF4G1 mutations implicate mRNA translation initiation
  in familial parkinsonism and highlight a convergent pathway for monogenic, toxin
  and perhaps virally-induced Parkinson disease.
raw_completion_output: |-
  primary_disease: Parkinson disease
  medical_actions: 
  symptoms: 
  chemicals: 
  action_annotation_relationships: 
prompt: |+
  From the text below, extract the following entities in the following format:

  primary_disease: <The main disease the text is about, or its central disease topic. This is often the disease mentioned in an article's title or in its first few sentences.>
  medical_actions: <Semicolon-separated list of medical actions, where each is a clinically prescribed procedure, therapy, intervention, or recommendation.>
  symptoms: <Semicolon-separated list of signs or symptoms.>
  chemicals: <Semicolon-separated list of chemicals or drugs>
  action_annotation_relationships: <Semicolon-separated list of relationships between a disease, the mentioned signs and symptoms associated with that disease, the medical actions relating to each symptom, and the type of relationship between each action and symptom (usually TREATS or PREVENTS). The disease name must be included in the relationship, for example, "treatment TREATS symptom IN disease". If the medical action includes a specific chemical or drug, include the chemical or drug name in the relationship, for example, "treatment (with chemical) TREATS symptom IN disease".>


  Text:
  Translation initiator EIF4G1 mutations in familial Parkinson disease.Genome-wide analysis of a multi-incident family with autosomal-dominant parkinsonism has implicated a locus on chromosomal region 3q26-q28. Linkage and disease segregation is explained by a missense mutation c.3614G>A (p.Arg1205His) in eukaryotic translation initiation factor 4-gamma (EIF4G1). Subsequent sequence and genotype analysis identified EIF4G1 c.1505C>T (p.Ala502Val), c.2056G>T (p.Gly686Cys), c.3490A>C (p.Ser1164Arg), c.3589C>T (p.Arg1197Trp) and c.3614G>A (p.Arg1205His) substitutions in affected subjects with familial parkinsonism and idiopathic Lewy body disease but not in control subjects. Despite different countries of origin, persons with EIF4G1 c.1505C>T (p.Ala502Val) or c.3614G>A (p.Arg1205His) mutations appear to share haplotypes consistent with ancestral founders. eIF4G1 p.Ala502Val and p.Arg1205His disrupt eIF4E or eIF3e binding, although the wild-type protein does not, and render mutant cells more vulnerable to reactive oxidative species. EIF4G1 mutations implicate mRNA translation initiation in familial parkinsonism and highlight a convergent pathway for monogenic, toxin and perhaps virally-induced Parkinson disease.

  ===

extracted_object:
  primary_disease: MONDO:0005180
named_entities:
  - id: MONDO:0008891
    label: Brown-Vialetto-Van Laere syndrome
  - id: MAXO:0009004
    label: exome sequencing
  - id: HP:0000407
    label: sensorineural hearing loss
  - id: HP:0002093
    label: respiratory insufficiency
  - id: HP:0010871
    label: sensory ataxia
  - id: HP:0000648
    label: optic atrophy
  - id: CHEBI:17015
    label: riboflavin
  - id: HP:0012469
    label: infantile spasms
  - id: HP:0000789
    label: infertility
  - id: HP:0005268
    label: miscarriage
  - id: CHEBI:16709
    label: pyridoxine
  - id: CHEBI:18405
    label: pyridoxal 5'-phosphate
  - id: CHEBI:27306
    label: vitamin B6
  - id: CHEBI:24041
    label: flavin mononucleotide
  - id: HP:0001250
    label: seizures
  - id: MONDO:0009974
    label: Familial hemophagocytic lymphohistiocytosis
  - id: MAXO:0010030
    label: bone marrow transplantation (BMT)
  - id: CHEBI:28901
    label: busulfan
  - id: CHEBI:4027
    label: cyclophosphamide
  - id: CHEBI:4911
    label: etoposide
  - id: MAXO:0000757
    label: infusion
  - id: CHEBI:41264
    label: busulfan (BU), cyclophosphamide (CP), etoposide (VP16), antithymocyte globulin
      (ATG)
  - id: MAXO:0000750
    label: conditioning regimen
  - id: CHEBI:73896
    label: gene therapy (GT)
  - id: MONDO:0009666
    label: Holocarboxylase synthetase deficiency
  - id: MAXO:0000603
    label: Peritoneal dialysis
  - id: HP:0001942
    label: Metabolic acidosis
  - id: CHEBI:15956
    label: Biotin
  - id: HP:0003256
    label: Coagulopathy
  - id: CHEBI:48669
    label: Tranexamic acid
  - id: CHEBI:48675
    label: antifibrinolytic agents
  - id: MONDO:0020300
    label: Autosomal dominant nocturnal frontal lobe epilepsy
  - id: CHEBI:3387
    label: Carbamazepine
  - id: MONDO:0000903
    label: Myoclonus-dystonia
  - id: MAXO:0000943
    label: Deep Brain Stimulation
  - id: HP:0001252
    label: Hypotonia
  - id: MONDO:0005338
    label: Primary open-angle glaucoma (POAG)
  - id: MAXO:0001082
    label: Trabeculectomy
  - id: MAXO:0000960
    label: Viscocanalostomy
  - id: HP:0007906
    label: Elevated intraocular pressure (IOP)
  - id: HP:0000253
    label: Progressive microcephaly
  - id: HP:0001263
    label: Global developmental delay
  - id: HP:0000365
    label: Hearing loss
  - id: HP:0100785
    label: Insomnia
  - id: CHEBI:15681
    label: GM3
  - id: CHEBI:28892
    label: Ganglioside
  - id: MAXO:0001298
    label: therapies
  - id: MAXO:0000950
    label: Supportive care
  - id: CHEBI:8378
    label: Prednisolone
  - id: MONDO:0015626
    label: Charcot-Marie-Tooth disease (CMT)
  - id: MAXO:0035087
    label: peripheral nerve biopsy
  - id: HP:0011096
    label: demyelination
  - id: HP:0001605
    label: vocal cord paralysis
  - id: MONDO:0007947
    label: Marfan's syndrome
  - id: HP:0001659
    label: aortic regurgitation
  - id: CHEBI:2904
    label: atenolol
  - id: CHEBI:6541
    label: losartan
  - id: MONDO:0004691
    label: Autosomal dominant polycystic kidney disease (ADPKD)
  - id: MAXO:0000004
    label: surgery
  - id: HP:0002586
    label: peritonitis
  - id: HP:0100543
    label: cognitive impairment
  - id: HP:0003546
    label: exercise intolerance
  - id: HP:0001332
    label: dystonia
  - id: HP:0001336
    label: myoclonus
  - id: HP:0001272
    label: cerebellar atrophy
  - id: HP:0002059
    label: cerebral atrophy
  - id: CHEBI:46245
    label: coenzyme Q10 (CoQ10)
  - id: MONDO:0009693
    label: multiple myeloma
  - id: HP:0002720
    label: IgA deficiency
  - id: HP:0006775
    label: multiple myeloma
  - id: MONDO:0011787
    label: Limb-girdle muscular dystrophy type 2I (LGMD2I)
  - id: MONDO:0009662
    label: Sly disease (mucopolysaccharidosis VII)
  - id: HP:0002321
    label: vertigo
  - id: HP:0040268
    label: recurrent infections of the middle ears
  - id: MONDO:0100137
    label: Telomere Diseases
  - id: HP:0005528
    label: Bone marrow failure
  - id: HP:0001394
    label: Liver cirrhosis
  - id: HP:0002206
    label: Pulmonary fibrosis
  - id: HP:0003394
    label: Muscle cramps
  - id: CHEBI:4315
    label: Danazol
  - id: MONDO:0015286
    label: complete DiGeorge syndrome (cDGS)
  - id: MAXO:0010042
    label: Thymus transplantation
  - id: HP:0001973
    label: Autoimmune thrombocytopenia
  - id: HP:0100646
    label: Thyroiditis
  - id: HP:0001875
    label: Neutropenia
  - id: HP:0012378
    label: fatigue
  - id: MONDO:0010421
    label: X-linked Agammaglobulinemia
  - id: MONDO:0005180
    label: Parkinson disease
